ArticleRadiology case reports2025
Case report on ureteral amyloidosis that was incidentally diagnosed in a patient with malignant lymphoma.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herein, we report a rare case of localized ureteral amyloidosis in a patient with malignant lymphoma. A 73-year-old female patient visited our institution for a comprehensive examination and treatment of malignant lymphoma. Contrast-enhanced computed tomography scan and magnetic resonance imaging revealed left hydronephrosis and a left lower ureteral mass. These findings suggested either ureteral amyloidosis or a ureteral carcinoma with significant fibrosis. Cystoscopic biopsy was performed, and the patient was pathologically diagnosed with ureteral amyloidosis. Renal renography revealed left renal dysfunction. However, the patient was asymptomatic. Hence, the patient should be followed-up for ureteral amyloidosis. Computed tomography scan were performed every 3 months, and after approximately 1 year, there was no evidence of mass enlargement. This case highlights the rarity of ureteral amyloidosis and the importance of imaging diagnosis in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.